Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Darunavir
Clonmel Healthcare Ltd
J05AE; J05AE10
Darunavir
600 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Protease inhibitors; darunavir
Marketed
2017-06-02
Page 1 of 10 PACKAGE LEAFLET: INFORMATION FOR THE USER DARUNAVIR CLONMEL 600 MG FILM-COATED TABLETS darunavir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Darunavir Clonmel is and what it is used for 2. What you need to know before you take Darunavir Clonmel 3. How to take Darunavir Clonmel 4. Possible side effects 5. How to store Darunavir Clonmel 6. Contents of the pack and other information 1. WHAT DARUNAVIR CLONMEL IS AND WHAT IT IS USED FOR WHAT IS DARUNAVIR CLONMEL? Darunavir Clonmel contains the active substance darunavir. Darunavir Clonmel is an antiretroviral medicine used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a group of medicines called protease inhibitors. Darunavir Clonmel works by reducing the amount of HIV in your body. This will improve your immune system and reduces the risk of developing illnesses linked to HIV infection. WHAT IT IS USED FOR? Darunavir Clonmel is used to treat adults and children of 3 years of age and above, and at least 15 kg body weight who are infected by HIV and who have already used other antiretroviral medicines. Darunavir Clonmel must be taken in combination with a low dose of ritonavir and other anti-HIV medicines. Your doctor will discuss with you which combination of medicines is best for you. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DARUNAVIR CLONMEL DO NOT TAKE DARUNAVIR CLONMEL • if you are ALLERGIC to darunavir or any of the other ingredients of this medicine (listed in section 6) or to ritonavir. • Read the complete document
Health║Products║Regulatory║Authority 02║November║2023 CRN00DSHR Page║1║of║33 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Darunavir║Clonmel║600║mg║film-coated║tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each║film‑coated║tablet║contains║600 mg║of║darunavir. ║ Excipient with known effect:║ Each║tablet║contains║2.592 mg║sunset║yellow║FCF║(E110). ║ For║the║full║list║of║excipients,║see║section║6.1. 3 PHARMACEUTICAL FORM Film‑coated║tablet. ║ Orange║oval║shaped║film║coated║tablet,║debossed║with║‘600’║on║one║side║and║plain║on║the║other║side,║with║dimensions║of║ approximately║20.1║mm║x║10.1║mm. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Darunavir║ Clonmel,║ co‑administered ║ with║ low║ dose║ ritonavir║ is║ indicated║ in║ combination║ with║ other║ antiretroviral║ medicinal║ products║for║the║treatment║of║patients║with║human║immunodeficiency║virus║(HIV‑1)║infection║(see║section║4.2). Darunavir║Clonmel║600 mg║tablets║may║be║used║to║provide║suitable║dose║regimens║(see║section║4.2): For║the║treatment║of║HIV‑1║infection║in║antiretroviral║treatment║(ART)‑experienced║adult║patients,║including║those║ that║have║been║highly║pre‑treated. For║the║treatment║of║HIV‑1║infection║in║paediatric║patients║from║the║age║of║3 years║and║at║least║15 kg║body║weight. In║deciding║to║initiate║treatment║with║Darunavir║Clonmel║co‑administered║with║low║dose║ritonavir,║careful║consideration║should║ be║given║to║the║treatment║history║of║the║individual║patient║and║the║patterns║of║mutations║associated║with║different║agents.║ Genotypic║or║phenotypic║testing║(when║available)║and║treatment║history║should║guide║the║use Read the complete document